• Welcome, introductions, and goals (by M Pai) [Slides]
• The big picture: global value chain for TB diagnostics (by M Pai) [Not available]
• Panel discussion: Scale-up of existing WHO-endorsed tools – country experiences and challenges [Not available]
• TB diagnostics pipeline: is the pipeline contracting? (by D Boyle) [Not available]
• Panel discussion: Can industry fill the gaps? What is the role of donors? [Not available]
• Panel discussion: Aligning the emerging TB drug and diagnostic pipelines [Not available]

Day 2 – 21 June 2016

• Next-generation TB tests: what do we need? (by C Denkinger) [Not available]
• Panel discussion: Optimal reference standards for test evaluation [Not available]
• Test accuracy with imperfect reference standard: the case of childhood TB (by N Dendukuri) [Not available]
• Advances in pediatric TB diagnosis (by M Tebruegge) [Not available]
• Diagnostic RCTs in TB: what have we learnt? (by C Denkinger) [Not available]
• Measuring clinical impact: methodological issues and challenges (by S Schumacher) [Not available]
• Improving case detection in high incidence settings: TB REACH experience (by J Creswell) [Not available]
• TB Tech Pitch [Not available]

Day 3 – 22 June 2016

• Implementation Science – rationale and application to TB diagnostics research (by A Katamba & A Cattamanchi) [Slides]
• Towards universal DST: Mumbai leads the way (by D Shah & R Jain) [Not available]
• Improving case detection in remote Arctic communities (by G Alvarez) [Not available]
• Qualitative research: how can it improve product design and implementation? (by N Engel) [Not available]
• IGRAs in low-risk healthcare workers: what have we learnt? (by N Banaei) [Not available]
• Panel discussion: Designing, developing & manufacturing diagnostics in LMICs [Slides]
• Panel discussion: Is sequencing the future of DST? [Not available]
• Improving access in the private sector: engaging private labs and pharmacies (by M Pai & H Dabas & A Daftary) [Not available]

Day 4 – 23 June 2016

• Systematic reviews of diagnostic accuracy (by K Steingart) [Slides]
• SR: case study: CAD for digital CXR (by T Pande) [Slides]
• SR: case study: Rapid CRP as a triage test (by A Cattamanchi) [Slides]
• SR: case study: Predictive value of IGRAs and TST (by S Kik) [Slides]
• Guideline development in TB diagnostics (by K Steingart) [Not available]
• Panel discussion: How do countries make policies on new diagnostics? [Not available]
• Panel discussion: Universal DST: pros and cons [Not available]
• Advocacy for improving TB diagnosis and care [Not available]

Day 5 – 24 June 2016

• Modeling of TB diagnostics (by D Dowdy) [Slides]
• Cost effectiveness analysis of TB diagnostics (by D Dowdy) [Not available]
• Challenges in modeling TB diagnostics (by D Dowdy) [Not available]
• Modeling for decision-making (by D Dowdy) [Not available]
• Panel discussion: Linking models to decision-making in public health & policy [Not available]
• Modeling and cost effectiveness: a synthesis (by D Dowdy) [Not available]